While agrifood innovation often celebrates bold founders and breakthrough technologies, what happens when the incentives of corporates, startups and investors don’t quite align?

In this live recording from evokeAG in Melbourne, Sarah Nolet is joined by Brad Fruth, Director of Innovation at Beck's Hybrids, and Frank Wooten, CEO of ArkeaBio and co-founder of Vence (acquired by Merck Animal Health).

Together, they explore the “sweet spot” of agtech innovation, i.e. the balance between what customers and corporations want, while recognizing the constraints that innovators and investors face.

Brad shares how Beck’s Hybrids, the largest family-owned retail seed company in the US, approaches innovation: rather than having a corporate venture arm, they focus on being internal problem-solvers and trusted matchmakers between startups.

Meanwhile, Frank Wooten speaks candidly about the realities of raising venture capital in agriculture; where billion-dollar exits are rare, timelines are long, and alignment with customers matters more than valuation headlines.

Sarah, Brad, and Frank discuss:

Why “free pilots” can devalue agtech products before they’ve proven themselves.
How corporations can support innovation without becoming distracted by it.
The risks founders face when fundraising incentives distort execution priorities.
The surprising advantages of Australian agriculture, from customer density to experimentation culture.

Useful Links:

For more information and resources, visit our website.

The information in this post is not investment advice or a recommendation to invest. It is general information only and does not take into account your investment objectives, financial situation or needs. Before making an investment decision you should seek financial advice from a professional financial adviser. Whilst we believe the information is correct, we provide no warranty of accuracy, reliability or completeness.